The state plans to buy packs of naloxone nasal spray, an opioid overdose treatment, for $24 per twin-pack. Eligible universities, first responders and community organizations can access the naloxone supply for free. The partnership will allow California to buy 3.2 million packs for the cost of 2 million at market price.
CalRx is also working on manufacturing its own insulin brand.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.